Significant Geographic Variation in Access to Certified Collagenase Injectors for Peyronie's Disease Throughout the United States.

Introduction: We characterize the geographic distribution of providers trained to inject and identify areas with low provider availability.

Methods: We utilized a publicly available search tool to identify clinical sites offering in the US The data gathered included the provider's name, specialty, address, and whether the site was considered high-volume (ie, administer ≥20 injections per year). Data were compared to the AUA Census.

Results: In total, 2,388 clinical sites offering were identified. A total of 894 sites (37%) were high-volume sites. The mean number of locations offering per 100,000 state residents was 0.69 (SD 0.27). Georgia (1.28), Rhode Island (1.13), and Alaska (1.10) had the highest number, whereas New Mexico (0.10), Maine (0.22), and Delaware (0.30) had the lowest. The mean proportion of urologists providing to total urologists was 0.17 (SD 0.07). The 3 states with the highest proportion were Georgia (0.37), Alaska (0.31), and Utah (0.30), whereas New Mexico (0.03), Maine (0.05), and Vermont (0.06) had the lowest.

Conclusions: States with low numbers of clinical sites offering per 100,000 residents relative to other states also had a low total ratio of urologists offering as a treatment. There is room for urologists in these states and others to expand their practice to offer and improve patient access to this important nonsurgical treatment option.